David McManus, MD, ScM, the Richard M. Haidack Professor of Medicine, chair, and professor of medicine in the Department of Medicine, recently discussed a collaboration with the Health AI Assurance Laboratory at UMass Chan and Red Cell Partners, an incubator and investment firm, to test and certify artificial intelligence products aimed at enhancing health care innovation and regulatory compliance. 

The two-year collaborative agreement with Red Cell Partners, which builds and launches technology-led health care, national security, and cyber startups, makes UMass Chan an established member of Red Cell’s Partners Advancing Critical Technologies program and allows UMass Chan to evaluate select AI health care products from Red Cell’s portfolio.  

“The partnership builds on a strength of UMass Chan,” said Dr. McManus, the founder of the Health AI Assurance Laboratory. “As early and serious market entrants, we have developed great talent, as well as the technical infrastructure, national network, and intramural governance to contribute meaningfully to industry partners like Red Cell.”  

Learn more about the collaboration in UMass Chan news.